Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia
出版年份 2016 全文链接
标题
Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia
作者
关键词
-
出版物
Science Translational Medicine
Volume 8, Issue 335, Pages 335ra56-335ra56
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2016-04-21
DOI
10.1126/scitranslmed.aad7653
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inherited erythromelalgia due to mutations inSCN9A:natural history, clinical phenotype and somatosensory profile
- (2016) Aoibhinn McDonnell et al. BRAIN
- From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial
- (2015) John McNeish et al. Cell Stem Cell
- Erythromelalgia Mutation Q875E Stabilizes the Activated State of Sodium Channel Nav1.7
- (2015) Theresa Stadler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel SCN9A Mutations Underlying Extreme Pain Phenotypes: Unexpected Electrophysiological and Clinical Phenotype Correlations
- (2015) E. C. Emery et al. JOURNAL OF NEUROSCIENCE
- Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848T gain-of-function mutation of Nav1.7
- (2015) Barbara Namer et al. PAIN
- Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H
- (2014) Dmytro V. Vasylyev et al. JOURNAL OF NEUROPHYSIOLOGY
- Painful and painless channelopathies
- (2014) David L H Bennett et al. LANCET NEUROLOGY
- Characterizing Human Stem Cell–derived Sensory Neurons at the Single-cell Level Reveals Their Ion Channel Expression and Utility in Pain Research
- (2014) Gareth T Young et al. MOLECULAR THERAPY
- Letter to the Editor
- (2014) Yigal Paul Goldberg et al. PAIN
- A new Nav1.7 mutation in an erythromelalgia patient
- (2013) Mark Estacion et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inherited Pain
- (2013) Mirjam Eberhardt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel SCN9A Mutation Responsible for Primary Erythromelalgia and Is Resistant to the Treatment of Sodium Channel Blockers
- (2013) Min-Tzu Wu et al. PLoS One
- Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors
- (2012) Stuart M Chambers et al. NATURE BIOTECHNOLOGY
- Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Nav1.7 mutant channel
- (2012) Yang Yang et al. Nature Communications
- Treatment of Nav1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker
- (2011) Yigal Paul Goldberg et al. PAIN
- Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navβ4 peptide-mediated resurgent sodium currents
- (2010) Jonathan W. Theile et al. JOURNAL OF PHYSIOLOGY-LONDON
- A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia
- (2009) Tanya Z. Fischer et al. ANNALS OF NEUROLOGY
- Early- and late-onset inherited erythromelalgia: genotype–phenotype correlation
- (2009) Chongyang Han et al. BRAIN
- Transfection of rat or mouse neurons by biolistics or electroporation
- (2009) Sulayman D Dib-Hajj et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now